Theoretical Investigation of the Structural Characteristics in the Active State of Akt1 Kinase

Akt (known as protein kinase B or PKB) is a serine/threonine kinase that regulates multiple biological processes, including cell growth, survival, and differentiation. Akt plays a critical role in the intracellular signaling network through conformational changes responsive to diverse signal inputs, and dysregulation of Akt activity could give rise to a number of diseases. However, understanding of Akt's dynamic structures and conformational transitions between active and inactive states remains unclear. In this work, classical MD simulations and QM/MM calculations were carried out to unveil the structural characteristics of Akt1, especially in its active state. The doubly protonated H194 was investigated, and both ATP-Akt1 and ADP-Akt1 complexes were constructed to demonstrate the significance of ATP in maintaining the ATP-K179-E198 salt bridge and the corresponding allosteric pathway. Besides, conformational transitions from the inactive state to the active state showed different permeation patterns of water molecules in the ATP pocket. The coordination modes of Mg2+ in the dominant representative conformations ( I and I') are presented. Unlike the water-free conformation I', three water molecules appear around Mg2+ in the water-occupied conformation I, which can finally exert an influence on the catalytic mechanism of Akt1. Furthermore, QM/MM calculations were performed to study the phosphoryl-transfer reaction of Akt1. The transfer of ATP γ-phosphate was achieved through a reversible conformational change from the reactant to a critical prereaction state, with a water molecule moving into the reaction center to coordinate with Mg2+, after which the γ-phosphate group was transferred from ATP to the substrate. Taken together, our results elucidate the structural characteristics of the Akt1 active state and shed new light on the catalytic mechanism of Akt kinases.

[1]  D. Truhlar,et al.  The M06 suite of density functionals for main group thermochemistry, thermochemical kinetics, noncovalent interactions, excited states, and transition elements: two new functionals and systematic testing of four M06-class functionals and 12 other functionals , 2008 .

[2]  J. Testa,et al.  Frequent activation of AKT in non-small cell lung carcinomas and preneoplastic bronchial lesions. , 2004, Carcinogenesis.

[3]  J. Kuriyan,et al.  Catalytic control in the EGF receptor and its connection to general kinase regulatory mechanisms. , 2011, Molecular cell.

[4]  H. Berendsen,et al.  Molecular dynamics with coupling to an external bath , 1984 .

[5]  Daniel R Roe,et al.  PTRAJ and CPPTRAJ: Software for Processing and Analysis of Molecular Dynamics Trajectory Data. , 2013, Journal of chemical theory and computation.

[6]  M. Karplus,et al.  A combined quantum mechanical and molecular mechanical potential for molecular dynamics simulations , 1990 .

[7]  Shu Cheng,et al.  Molecular Dynamics Simulations and Elastic Network Analysis of Protein Kinase B (Akt/PKB) Inactivation , 2010, J. Chem. Inf. Model..

[8]  Andrew K Godwin,et al.  AKT and mTOR phosphorylation is frequently detected in ovarian cancer and can be targeted to disrupt ovarian tumor cell growth , 2004, Oncogene.

[9]  E. Hirsch,et al.  PI3K/AKT signaling pathway and cancer: an updated review , 2014, Annals of medicine.

[10]  B. Brandhuber,et al.  An ATP-Site On-Off Switch That Restricts Phosphatase Accessibility of Akt , 2012, Science Signaling.

[11]  J. Cheong,et al.  Constitutive phosphorylation of Akt/PKB protein in acute myeloid leukemia: its significance as a prognostic variable , 2003, Leukemia.

[12]  A. Toker,et al.  AKT/PKB Signaling: Navigating the Network , 2017, Cell.

[13]  Ruth Nussinov,et al.  The Mechanism of ATP-Dependent Allosteric Protection of Akt Kinase Phosphorylation. , 2015, Structure.

[14]  José L Medina-Franco,et al.  In search of AKT kinase inhibitors as anticancer agents: structure-based design, docking, and molecular dynamics studies of 2,4,6-trisubstituted pyridines , 2018, Journal of biomolecular structure & dynamics.

[15]  Olle Stål,et al.  Akt kinases in breast cancer and the results of adjuvant therapy , 2003, Breast Cancer Research.

[16]  D. Littler,et al.  Structure of human protein kinase C eta (PKCeta) C2 domain and identification of phosphorylation sites. , 2006, Biochemical and biophysical research communications.

[17]  D. Barford,et al.  Molecular mechanism for the regulation of protein kinase B/Akt by hydrophobic motif phosphorylation. , 2002, Molecular cell.

[18]  Gang Li,et al.  The RAS/RAF/MEK/ERK and PI3K/AKT signaling pathways present molecular targets for the effective treatment of advanced melanoma. , 2005, Frontiers in bioscience : a journal and virtual library.

[19]  Jian Zhang,et al.  Mechanism for the autophosphorylation of CheA histidine kinase: QM/MM calculations. , 2011, The journal of physical chemistry. B.

[20]  Hua Guo,et al.  Insights into the phosphoryl transfer mechanism of cyclin-dependent protein kinases from ab initio QM/MM free-energy studies. , 2011, The journal of physical chemistry. B.

[21]  P. Kollman,et al.  A Second Generation Force Field for the Simulation of Proteins, Nucleic Acids, and Organic Molecules , 1995 .

[22]  Marat Valiev,et al.  Phosphorylation reaction in cAPK protein kinase-free energy quantum mechanical/molecular mechanics simulations. , 2007 .

[23]  Jian Lu,et al.  QM/MM-PB/SA scoring of the interaction strength between Akt kinase and apigenin analogues , 2014, Comput. Biol. Chem..

[24]  François Diederich,et al.  Addressing the Glycine-Rich Loop of Protein Kinases by a Multi-Facetted Interaction Network: Inhibition of PKA and a PKB Mimic. , 2016, Chemistry.

[25]  Lewis C. Cantley,et al.  AKT/PKB Signaling: Navigating Downstream , 2007, Cell.

[26]  Shaoyong Lu,et al.  Microsecond molecular dynamics simulations provide insight into the ATP‐competitive inhibitor‐induced allosteric protection of Akt kinase phosphorylation , 2017, Chemical biology & drug design.

[27]  Jan H. Jensen,et al.  PROPKA3: Consistent Treatment of Internal and Surface Residues in Empirical pKa Predictions. , 2011, Journal of chemical theory and computation.

[28]  Marian Anghel,et al.  Synchronization of trajectories in canonical molecular-dynamics simulations: observation, explanation, and exploitation. , 2004, The Journal of chemical physics.

[29]  Thom Vreven,et al.  Combining Quantum Mechanics Methods with Molecular Mechanics Methods in ONIOM. , 2006, Journal of chemical theory and computation.

[30]  Jan H. Jensen,et al.  Very fast prediction and rationalization of pKa values for protein–ligand complexes , 2008, Proteins.

[31]  Yong Liao,et al.  Physiological regulation of Akt activity and stability. , 2010, American journal of translational research.

[32]  T. Darden,et al.  Particle mesh Ewald: An N⋅log(N) method for Ewald sums in large systems , 1993 .

[33]  John E. Burke,et al.  Conformational sampling of membranes by Akt controls its activation and inactivation , 2018, Proceedings of the National Academy of Sciences.

[34]  B. Nagar,et al.  c-Abl tyrosine kinase and inhibition by the cancer drug imatinib (Gleevec/STI-571). , 2007, The Journal of nutrition.

[35]  Nathan A. Baker,et al.  PDB2PQR: an automated pipeline for the setup of Poisson-Boltzmann electrostatics calculations , 2004, Nucleic Acids Res..

[36]  Alona Muzikansky,et al.  The prognostic significance of phosphatidylinositol 3-kinase pathway activation in human gliomas. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[37]  Lisa Yan,et al.  A fast and accurate computational approach to protein ionization , 2008, Protein science : a publication of the Protein Society.

[38]  O. Issinger,et al.  Crystal structure of human protein kinase CK2: insights into basic properties of the CK2 holoenzyme , 2001, The EMBO journal.

[39]  Jan H. Jensen,et al.  Very fast empirical prediction and rationalization of protein pKa values , 2005, Proteins.

[40]  Q. Peng,et al.  Akt inhibitors in cancer treatment: The long journey from drug discovery to clinical use (Review) , 2015, International journal of oncology.

[41]  Roger S. Armen,et al.  Resistance of Akt kinases to dephosphorylation through ATP-dependent conformational plasticity , 2011, Proceedings of the National Academy of Sciences.

[42]  Lenwood S. Heath,et al.  H++: a server for estimating pKas and adding missing hydrogens to macromolecules , 2005, Nucleic Acids Res..

[43]  Brian A. Hemmings,et al.  Crystal structure of an activated Akt/Protein Kinase B ternary complex with GSK3-peptide and AMP-PNP , 2002, Nature Structural Biology.

[44]  G. Ciccotti,et al.  Numerical Integration of the Cartesian Equations of Motion of a System with Constraints: Molecular Dynamics of n-Alkanes , 1977 .

[45]  정준원,et al.  Phosphatase and tensin homologue phosphorylation in the C-terminal regulatory domain is frequently observed in acute myeloid leukaemia and associated with poor clinical outcome , 2003 .

[46]  B. Hemmings,et al.  Structure, regulation and function of PKB/AKT--a major therapeutic target. , 2004, Biochimica et biophysica acta.

[47]  Jian Lu,et al.  The non-additive contribution of hydroxyl substituents to Akt kinase–apigenin affinity , 2015 .